enVVeno Medical Corp Net Income Loss

• enVVeno Medical Corp showed an increase of +10.8% in Net Income Loss from 2024 to 2025.
• This data is from enVVeno Medical Corp's annual report (Form 10-K), filed with the SEC on March 26, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), enVVeno Medical Corp's Net Income Loss has declined by 149.9%.
• Historical annual values: Fiscal year 2025: -$19.47 million | Fiscal year 2024: -$21.82 million | Fiscal year 2023: -$23.52 million | Fiscal year 2022: -$24.67 million | Fiscal year 2021: -$16.53 million | Fiscal year 2020: -$9.14 million | Fiscal year 2019: -$7.63 million | Fiscal year 2018: -$13.04 million | Fiscal year 2017: -$7.79 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026